Preeclampsia is associated with increased maternal body weight in a northeastern Brazilian population

BMC Pregnancy and Childbirth

Volumn 13, Issue , 2013, Pages

  Dantas, Edailna M D M ^a   Pereira, Flávio V M ^a   Queiroz, José W ^a,b   Dantas, Diogo L D M ^c   Monteiro, Gloria R G ^a,b,d   Duggal, Priya ^e   Azevedo, Maria D F ^c   Jeronimo, Selma M B ^a,b,c,d   Araújo, Ana Cristina P F ^a,c  

^a Federal do Rio Grande do Norte   (Brazil)

^b Federal Institute of Rio Grande do Norte (IFRN)   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^d Institute of Science and Technology of Tropical Diseases (INCT DT)   (Brazil)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

BMI; Hypertension; Obesity; Preeclampsia; Pregnancy

Indexed keywords

ANTICONVULSIVE AGENT; CREATININE;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; BRAZIL; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GESTATIONAL AGE; HEALTH CENTER; HELLP SYNDROME; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL HYPERTENSION; MATERNAL NUTRITION; MATERNAL OBESITY; MEDICAL CARE; PATIENT COMPLIANCE; POPULATION DENSITY; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PROSPECTIVE STUDY; RISK FACTOR; SPONTANEOUS ABORTION; SYSTOLIC BLOOD PRESSURE; WEIGHT GAIN;

ADOLESCENT; ADULT; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; BRAZIL; CASE-CONTROL STUDIES; CREATININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; URBAN POPULATION; YOUNG ADULT;

EID: 84881184833     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-13-159     Document Type: Article

References (55)

1. Sibai BM, Spinnato JA, Watson DL, Hill GA, Anderson GD. Pregnancy outcome in 303 cases with severe preeclampsia. Obstet Gynecol 1984, 64:319-325.
2. Sibai BM, Abdella TN, Anderson GD. Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol 1983, 61:571-576.
3. Belghiti J, Kayem G, Tsatsaris V, Goffinet F, Sibai BM, Haddad B. Benefits and risks of expectant management of severe preeclampsia at less than 26 weeks gestation: the impact of gestational age and severe fetal growth restriction. Am J Obstet Gynecol 2011, 205:465-466.
4. Bodnar LM, Catov JM, Roberts JM. Racial/ethnic differences in the monthly variation of preeclampsia incidence. Am J Obstet Gynecol 2007, 196:324-325.
5. Cripe SM, O'Brien W, Gelaye B, Williams MA. Perinatal outcomes of Southeast Asians with pregnancies complicated by gestational diabetes mellitus or preeclampsia. JImmigr Minor Health 2012, 14:747-753.
6. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 2008, 112(2 Pt 1):359-372.
7. Sibai BM. Preeclampsia as a cause of preterm and late preterm (near-term) births. Semin Perinatol 2006, 30:16-19.
8. Von DP, Magee L. What matters in preeclampsia are the associated adverse outcomes: the view from Canada. Curr Opin Obstet Gynecol 2008, 20:110-115.
9. Sibai BM. Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gynecol 2012, 206:470-475.
10. Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol 2008, 198:7-22.
11. Conde-Agudelo A, Belizan JM, Diaz-Rossello JL. Epidemiology of fetal death in Latin America. Acta Obstet Gynecol Scand 2000, 79:371-378.
12. Delahaije DH, van Kuijk SM, Dirksen CD, Sep SJ, Peeters LL, Spaanderman ME, et al. Cost-effectiveness of recurrence risk guided care versus care as usual in women who suffered from early-onset preeclampsia including HELLP syndrome in their previous pregnancy (the PreCare study). BMC Pregnancy Childbirth 2010, 10:60.
13. Strufaldi MW, Silva EM, Puccini RF. Metabolic syndrome among prepubertal Brazilian schoolchildren. Diab Vasc Dis Res 2008, 5:291-297.
14. Valerio EG, Muller AL, Martins-Costa SH, Lopes Ramos JG, Rodini G. Are insulin resistance index, IGF-1 and metabolic syndrome components correlates with severe preeclampsia?. Hypertens Pregnancy 2011, 30:302-310.
15. Strufaldi MW, da Silva EM, Puccini RF. Insulin resistance among Brazilian schoolchildren: association with risk factors for cardiovascular diseases. Acta Paediatr 2009, 98:1646-1650.
16. Ramos AV, Bastos-Rodrigues L, Resende BA, Friedman E, Campanha-Versiani L, Miranda DM, et al. The contribution of FTO and UCP-1 SNPs to extreme obesity, diabetes and cardiovascular risk in Brazilian individuals. BMC Med Genet 2012, 13:101.
17. Siqueira FM, Cota LO, Costa JE, Haddad JP, Lana AM, Costa FO. Maternal periodontitis as a potential risk variable for preeclampsia: a case-control study. J Periodontol 2008, 79:207-215.
18. Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens 2008, 21:521-526.
19. Payne B, Magee LA, Cote AM, Hutcheon JA, Li J, Kyle PM, et al. PIERS proteinuria: relationship with adverse maternal and perinatal outcome. J Obstet Gynaecol Can 2011, 33:588-597.
20. Menzies J, Magee LA, Macnab YC, Ansermino JM, Li J, Douglas MJ, et al. Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes. Hypertens Pregnancy 2007, 26:447-462.
21. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000, 183:S1-S22.
22. O'Brien E, Staessen JA. Critical appraisal of the JNC VI, WHO/ISH and BHS guidelines for essential hypertension. Expert Opin Pharmacother 2000, 1:675-682.
23. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves JW, Hill MN, et al. Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich) 2005, 7:102-109.
24. Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol 2012, 36:56-59.
25. Saadat M, Nejad SM, Habibi G, Sheikhvatan M. Maternal and neonatal outcomes in women with preeclampsia. Taiwan J Obstet Gynecol 2007, 46:255-259.
26. Habli M, Levine RJ, Qian C, Sibai B. Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. Am J Obstet Gynecol 2007, 197:406-407.
27. Abramovici D, Friedman SA, Mercer BM, Audibert F, Kao L, Sibai BM. Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter?. Am J Obstet Gynecol 1999, 180(1 Pt 1):221-225.
28. Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol 1990, 163:460-465.
29. Rudra CL, Williams MA. BMI as a modifying factor in the relations between age at menarche, menstrual cycle characteristics, and risk of preeclampsia. Gynecol Endocrinol 2005, 21:200-205.
30. Sibai BM, Gordon T, Thom E, Caritis SN, Klebanoff M, McNellis D, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 1995, 172(2 Pt 1):642-648.
31. Belogolovkin V, Eddleman KA, Malone FD, Sullivan L, Ball RH, Nyberg DA, et al. The effect of low body mass index on the development of gestational hypertension and preeclampsia. J Matern Fetal Neonatal Med 2007, 20:509-513.
32. Walsh SW. Obesity: a risk factor for preeclampsia. Trends Endocrinol Metab 2007, 18:365-370.
33. McDonald SD, Yusuf S, Walsh MW, Lonn E, Teo K, Anand SS, et al. Increased cardiovascular risk after pre-eclampsia in women with dysglycaemia. Diabet Med 2013, 30:e1-e7.
34. Marasciulo FL, Montagnani M, Potenza MA. Endothelin-1: the yin and yang on vascular function. Curr Med Chem 2006, 13:1655-1665.
35. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001, 323:1213-1217.
36. Skjaerven R, Wilcox AJ, Klungsoyr K, Irgens LM, Vikse BE, Vatten LJ, et al. Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study. BMJ 2012, 345:e7677.
37. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005, 366:1797-1803.
38. Wikstrom AK, Haglund B, Olovsson M, Lindeberg SN. The risk of maternal ischaemic heart disease after gestational hypertensive disease. BJOG 2005, 112:1486-1491.
39. Wikstrom AK, Stephansson O, Cnattingius S. Previous preeclampsia and risks of adverse outcomes in subsequent nonpreeclamptic pregnancies. Am J Obstet Gynecol 2011, 204:148-6.
40. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007, 335:974.
41. Fortner RT, Pekow P, Solomon CG, Markenson G, Chasan-Taber L. Prepregnancy body mass index, gestational weight gain, and risk of hypertensive pregnancy among Latina women. Am J Obstet Gynecol 2009, 200:167.
42. Fortner RT, Pekow PS, Whitcomb BW, Sievert LL, Markenson G, Chasan-Taber L. Physical activity and hypertensive disorders of pregnancy among Hispanic women. Med Sci Sports Exerc 2011, 43:639-646.
43. Vitolo MR, Bueno MS, Gama CM. Impact of a dietary counseling program on the gain weight speed of pregnant women attended in a primary care service. Rev Bras Ginecol Obstet 2011, 3:58-59.
44. Moreira MA, Cabral PC, Ferreira HS, Lira PI. Overweight and associated factors in children from northeastern Brazil. J Pediatr (Rio J) 2012, 88:347-352.
45. Hsu CD, Witter FR. Urogenital infection in preeclampsia. Int J Gynaecol Obstet 1995, 49:271-275.
46. Virk J, Hsu P, Olsen J. Socio-demographic characteristics of women sustaining injuries during pregnancy: a study from the Danish National Birth Cohort. BMJ Open 2012, 2(4).
47. Souza JP, Gülmezoglu AM, Vogel J, Carroli G, Lumbiganon P, Qureshi Z, et al. Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study. Lancet 2013, 381:1747-1755.
48. Okafor UV, Ezegwui HU. Cesarean delivery in preeclampsia and seasonal variation in a tropical rainforest belt. J Postgrad Med 2010, 56:21-23.
49. Chu K, Cortier H, Maldonado F, Mashant T, Ford N, Trelles M. Cesarean section rates and indications in sub-Saharan Africa: a multi-country study from Medecins sans Frontieres. PLoS One 2012, 7:e44484.
50. Freitas PF, Drachler ML, Leite JC, Grassi PR. Social inequalities in cesarean section rates in primiparae, Southern Brazil. Rev Saude Publica 2005, 39:761-767.
51. Lumbiganon P, Laopaiboon M, Gulmezoglu AM, Souza JP, Taneepanichskul S, Ruyan P, et al. Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal and perinatal health 2007-08. Lancet 2010, 375:490-499.
52. Brink A, Akande W, Moodley J, Hague W, Hall D, Steyn W, et al. Hypertension in pregnancy. Cardiovasc J S Afr 2002, 13:68-72.
53. O'Connor HD, Hehir MP, Kent EM, Foley ME, Fitzpatrick C, Geary MP, et al. Eclampsia: Trends in Incidence and Outcomes over 30 Years. Am J Perinatol 2012
54. Villar J, Valladares E, Wojdyla D, Zavaleta N, Carroli G, Velazco A, et al. Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America. Lancet 2006, 367:1819-1829.
55. Bezerra PC, Leao MD, Queiroz JW, Melo EM, Pereira FV, Nobrega MH, et al. Family history of hypertension as an important risk factor for the development of severe preeclampsia. Acta Obstet Gynecol Scand 2010, 89:612-617.